her2+ bc with lymphocytes relapses less...

[RobinP]

http://www.broad.mit.edu/publications/broad824

Here's the correct link, Becky, which I also fixed in my above post. Looks like they are referring to lymphocytes in the pathology report decrease mets in node negative her2+bc. I think those with lymphocytes are displaying more robust immunity in response to cancerous breast cells, thus, delaying spread to lymph nodes and elsewhere.